News
Final overall survival results from the Phase III APHINITY trial show a 17% reduction in the risk of death at 10 years for ...
In this video interview, Krinx Kong, chief commercial officer, Cognivia, discusses how clinical operations professionals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback